FilingPulse

CALC insider transaction filings

CalciMedica, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-24. Screen CALC transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 15 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Middleton Fred A — Director, 10% owner11 leg · 248,972 sh · $199,999——
WILSON ROBERT N — Director2——4
Zaytsev Evgeny — Director2——4
Hebbar Sudarshan — Chief Medical Officer2——3
Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director2——3
Roberts Eric W — CHIEF BUSINESS OFFICER, Director2——3
ALAFI CAPITAL CO LLC — 10% owner1——2
Glicklich Alan — Director1——1
Guerard Frederic — Director1——1
Shaw Allan — Director1——1

Recent Form 4 filings — CalciMedica, Inc.

FiledFormInsiderReported transactionsSource
2026-08-244ALAFI CAPITAL CO LLC — 10% ownerGrant/award (A): 3,529,192 (derivative) @ $0 · Grant/award (A): 3,529,192 (derivative) @ $0EDGAR
2026-08-214Glicklich Alan — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-08-214Shaw Allan — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-08-214Zaytsev Evgeny — DirectorGrant/award (A): 1,450,267 (derivative) @ $0 · Grant/award (A): 1,450,267 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-08-214Guerard Frederic — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-08-214WILSON ROBERT N — DirectorGrant/award (A): 1,182,621 (derivative) @ $0 · Grant/award (A): 1,182,621 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-08-214Hebbar Sudarshan — Chief Medical OfficerGrant/award (A): 124,486 (derivative) @ $0 · Grant/award (A): 124,486 (derivative) @ $0EDGAR
2026-08-214Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 186,729 (derivative) @ $0 · Grant/award (A): 186,729 (derivative) @ $0EDGAR
2026-08-214Roberts Eric W — CHIEF BUSINESS OFFICER, DirectorGrant/award (A): 186,729 (derivative) @ $0 · Grant/award (A): 186,729 (derivative) @ $0EDGAR
2026-07-074Zaytsev Evgeny — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2026-06-294Hebbar Sudarshan — Chief Medical OfficerGrant/award (A): 124,486 @ $0.80EDGAR
2026-06-294Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerGrant/award (A): 186,729 @ $0.80EDGAR
2026-06-294Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% ownerGrant/award (A): 186,729 @ $0.80EDGAR
2026-06-294Middleton Fred A — Director, 10% ownerPurchase (P): 248,972 @ $0.80EDGAR
2026-06-294WILSON ROBERT N — DirectorGrant/award (A): 1,182,621 @ $0.80EDGAR
2026-04-074Stauderman Kenneth A. — Chief Scientific OfficerGrant/award (A): 65,124 (derivative) @ $0EDGAR
2026-04-074Hebbar Sudarshan — Chief Medical OfficerGrant/award (A): 91,173 (derivative) @ $0EDGAR
2026-04-074Dunn Michael J. — President and COOGrant/award (A): 65,124 (derivative) @ $0EDGAR
2026-04-074Bardin Stephen — Chief Financial OfficerGrant/award (A): 67,728 (derivative) @ $0EDGAR
2026-04-074Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerGrant/award (A): 83,358 (derivative) @ $0EDGAR
2026-04-074Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% ownerGrant/award (A): 148,482 (derivative) @ $0EDGAR
2025-10-144Glicklich Alan — DirectorGrant/award (A): 937 (derivative) @ $0EDGAR
2025-09-224Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 2,500 @ $3.07EDGAR
2025-09-174Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 3,400 @ $2.68EDGAR
2025-09-154Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 5,000 @ $3.12EDGAR
2025-09-114Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 2,343 @ $3.15EDGAR
2025-09-024Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 9,200 @ $2.86 · Purchase (P): 800 @ $2.74EDGAR
2025-08-254Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 3,508 @ $2.79EDGAR
2025-08-214Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 1,000 @ $2.79 · Purchase (P): 2,000 @ $2.72 · Option exercise (M): 15,000 @ $1.53 · Option exercise (M): 15,000 (derivative) @ $1.53EDGAR
2025-08-214Hebbar Sudarshan — Chief Medical OfficerPurchase (P): 9,563 @ $2.82EDGAR
2025-08-194Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 5,076 @ $2.90EDGAR
2025-08-184Hebbar Sudarshan — Chief Medical OfficerPurchase (P): 1,584 @ $2.58 · Purchase (P): 4,392 @ $2.79EDGAR
2025-07-294Stauderman Kenneth A. — Chief Scientific OfficerSale (S): 1,000 @ $3.65 · Purchase (P): 1,000 @ $3.96EDGAR
2025-07-234Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 1,500 @ $3.77EDGAR
2025-07-224Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 1,500 @ $3.37EDGAR
2025-07-214Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% ownerPurchase (P): 1,000 @ $3.40EDGAR
2025-07-184Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 2,000 @ $2.88EDGAR
2025-07-184WILSON ROBERT N — DirectorPurchase (P): 4,500 @ $2.87EDGAR
2025-07-164Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 6,500 @ $2.43EDGAR
2025-07-154Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% ownerPurchase (P): 2,500 @ $2.47EDGAR
2025-07-104Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 5,000 @ $1.60EDGAR
2025-07-024Stauderman Kenneth A. — Chief Scientific OfficerPurchase (P): 1,000 @ $1.85EDGAR
2025-06-274Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% ownerPurchase (P): 4,500 @ $1.44EDGAR
2025-06-264Dunn Michael J. — President and COOGrant/award (A): 47,125 (derivative) @ $0EDGAR
2025-06-264Guerard Frederic — DirectorGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-06-264Glicklich Alan — DirectorGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 4,166 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-06-264Shaw Allan — DirectorGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,594 (derivative) @ $0 · Grant/award (A): 26,250 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-06-264Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% ownerGrant/award (A): 77,625 (derivative) @ $0EDGAR
2025-06-264MIDDLETON FRED A — Director, 10% ownerGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 6,562 (derivative) @ $0 · Grant/award (A): 19,687 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-06-264WILSON ROBERT N — DirectorGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 12,031 (derivative) @ $0 · Grant/award (A): 36,562 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR

Recent 8-K events — CalciMedica, Inc.

FiledFormItems reportedSource
2026-09-168-K8.01 — Other EventsEDGAR
2026-09-028-K8.01 — Other EventsEDGAR
2026-08-278-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-248-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-248-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CALC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →